Which countries will Clavicular visit in 2026?
As of Sat, 07 Nov 2026 03:41:26 UTC, Polymarket traders price Japan (23.0%), Thailand (16.3%), South Korea (15.3%). The market has $29K in volume and closes on Fri, 01 Jan 2027.
Updated:
Current odds
| Outcome | Chance | Yes price | No price |
|---|---|---|---|
| Japan | 23.0% | 23.0¢ | 77.0¢ |
| Thailand | 16.3% | 16.3¢ | 83.8¢ |
| South Korea | 15.3% | 15.3¢ | 84.7¢ |
| Colombia | 14.0% | 14.0¢ | 86.0¢ |
| Philippines | 13.5% | 13.5¢ | 86.5¢ |
| Russia | 13.0% | 13.0¢ | 87.0¢ |
| Brazil | 12.8% | 12.8¢ | 87.2¢ |
| United Kingdom | 12.5% | 12.5¢ | 87.5¢ |
| China | 4.8% | 4.8¢ | 95.2¢ |
| Germany | 4.8% | 4.8¢ | 95.2¢ |
| North Korea | 3.0% | 3.0¢ | 97.0¢ |
| Iran | 2.5% | 2.5¢ | 97.5¢ |
Market details
- Venue: Polymarket
- Volume: $29K
- Liquidity: $6K
- Closes:
Resolution rules
If Clavicular, otherwise known as Braden Peters, visits a listed country between market creation and December 31, 2026, 11:59 PM ET, the relevant market will resolve to "Yes". Otherwise, this market will resolve to "No". For the purpose of this market, a "visit" is defined as Clavicular physically entering the terrestrial or maritime territory of the listed country. Whether or not Clavicular enters the country's airspace during the timeframe of this market will have no bearing on a positive resolution. For the purposes of this market, "China" includes all territory administered by the People's Republic of China, including Special Administrative Regions, excluding Taiwan. The resolution source for this market will be a consensus of credible reporting.
Sources
Related markets
- Clavicular sentenced to prison by...?
- Highest grossing movie in 2026?
- Bachelorette Season 22 Winner
- Where will 2026 rank among the hottest years on record?
- Richest person on December 31, 2026?
- Will the Doge-1 Lunar Mission launch by...?
DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.